Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CardieX ( (AU:CDX) ) has shared an update.
CardieX Limited reported its quarterly cash flow, highlighting a net cash outflow from operating activities of $2.058 million, primarily due to substantial staff and administrative costs. Despite a challenging quarter, the company secured $250,000 from C2 Ventures Funding Commitment Agreement and other share applications, contributing to a net cash inflow from financing activities of $7.923 million year-to-date, which could bolster its financial position and support ongoing operations.
More about CardieX
CardieX Limited operates in the health technology industry, focusing on the development and commercialization of medical devices and digital solutions for cardiovascular health management. The company targets both consumer and clinical markets, aiming to provide innovative solutions for monitoring and managing heart health.
Technical Sentiment Signal: Sell
Current Market Cap: $14.85M
Learn more about CDX stock on TipRanks’ Stock Analysis page.